Sachin G. Thakkar

Baylor College of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Collaborators (7)

Xin Xu

Assistant Professor

Baylor College of Medicine

UNITED STATES

View details

Winfried Wels

GERMANY

View details

Claudia Martinez

University of Florida

UNITED STATES

View details

LaQuisa Hill

Assistant Professor

Baylor College of Medicine

UNITED STATES

View details

Norihiro Watanabe

Baylor College of Medicine

UNITED STATES

View details

Andras Heczey

Associate professor

Baylor College of Medicine

UNITED STATES

View details

Shoba Navai

Assistant Professor

Baylor College of Medicine Department of Pediatrics

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sachin G. Thakkar

Research Interests

Explore related searches

Contact this professor

Articles (10)

Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers

Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial

Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors

Incipient clonal hematopoiesis is accelerated following CD30.CAR-T therapy

Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies

Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results

Enhanced anti-tumor activity of CD5 CAR T cells manufactured with tyrosine kinase inhibitors in patients with relapsed/refractory T-ALL.

OFF‐THE‐SHELF CD30.CAR‐MODIFIED EPSTEIN‐BARR VIRUS‐SPECIFIC T CELLS (CD30.CAR EBVSTS) PROVIDE A SAFE AND EFFECTIVE THERAPY FOR PATIENTS WITH HODGKIN LYMPHOMA (HL)

CD30.CAR-Modified Epstein-Barr Virus-Specific T Cells (CD30.CAR EBVSTs) Provide a Safe and Effective Off-the-Shelf Therapy for Patients with CD30-Positive Lymphoma

Safety and Efficacy of Off-the-Shelf CD30.CAR-Modified Epstein-Barr Virus-Specific T Cells in Patients with CD30-Positive Lymphoma

Collaborators (7)

Xin Xu

Winfried Wels

Claudia Martinez

LaQuisa Hill

Norihiro Watanabe

Andras Heczey

Shoba Navai

Make your next move.